Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes

Apoptosis: A Review of Programmed Cell Death

Elmore, S. (2007) · Toxicologic Pathology · doi:10.1080/01926230701320337 · Cited by 13,853

Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells

Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310

ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction: Executive Summary and Recommendations: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina)

Braunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D., Kupersmith, J., Levin, T. N., et al. (2000) · Circulation · doi:10.1161/01.cir.102.10.1193 · Cited by 4,487

Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis

Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., et al. (1995) · Nature · doi:10.1038/376037a0 · Cited by 3,979

Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity

Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,778

Identification of the molecular basis of doxorubicin-induced cardiotoxicity

Zhang, S., Liu, X., Bawa-Khalfe, T., Lu, L.-S., Lyu, Y. L., Liu, L. F., & Yeh, E. T. H. (2012) · Nature Medicine · doi:10.1038/nm.2919 · Cited by 1,948

Doxorubicin-Induced Cardiomyopathy

Singal, P. K., & Iliskovic, N. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809243391307 · Cited by 1,845

Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment

Volkova, M., & Russell, R. (2012) · Current Cardiology Reviews · doi:10.2174/157340311799960645 · Cited by 872

Cell Death in the Pathogenesis of Heart Disease: Mechanisms and Significance

Whelan, R. S., Kaplinskiy, V., & Kitsis, R. N. (2010) · Annual Review of Physiology · doi:10.1146/annurev.physiol.010908.163111 · Cited by 759

Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity

Burridge, P. W., Li, Y. F., Matsa, E., Wu, H., Ong, S.-G., Sharma, A., Holmström, A., Chang, A. C., Coronado, M. J., Ebert, A. D., et al. (2016) · Nature Medicine · doi:10.1038/nm.4087 · Cited by 742

Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL

Wagner, K. W., Punnoose, E. A., Januario, T., Lawrence, D. A., Pitti, R. M., Lancaster, K., Lee, D., von Goetz, M., Yee, S. F., Totpal, K., et al. (2007) · Nature Medicine · doi:10.1038/nm1627 · Cited by 612

Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy

Cardinale, D., Sandri, M. T., Martinoni, A., Tricca LabTech, A., Civelli, M., Lamantia, G., Cinieri, S., Martinelli, G., Cipolla, C. M., & Fiorentini, C. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00748-8 · Cited by 551

Cardiomyocyte death: mechanisms and translational implications

Chiong, M., Wang, Z. V., Pedrozo, Z., Cao, D. J., Troncoso, R., Ibacache, M., Criollo, A., Nemchenko, A., Hill, J. A., & Lavandero, S. (2011) · Cell Death & Disease · doi:10.1038/cddis.2011.130 · Cited by 491

Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human

Haghighi, K., Kolokathis, F., Pater, L., Lynch, R. A., Asahi, M., Gramolini, A. O., Fan, G.-C., Tsiapras, D., Hahn, H. S., Adamopoulos, S., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17892 · Cited by 478

Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology Recommendations of the Task Force of the European Society of Cardiology

Bertrand, M. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2301 · Cited by 410

Predictive Value of Cardiac Troponin T in Pediatric Patients at Risk for Myocardial Injury

Lipshultz, S. E., Rifai, N., Sallan, S. E., Lipsitz, S. R., Dalton, V., Sacks, D. B., & Ottlinger, M. E. (1997) · Circulation · doi:10.1161/01.cir.96.8.2641 · Cited by 384

Cardiotoxicity of Cancer Therapy

Floyd, J. D., Nguyen, D. T., Lobins, R. L., Bashir, Q., Doll, D. C., & Perry, M. C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.789 · Cited by 372

Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy

Cardinale, D., Sandri, M. T., Martinoni, A., Borghini, E., Civelli, M., Lamantia, G., Cinieri, S., Martinelli, G., Fiorentini, C., & Cipolla, C. M. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf170 · Cited by 313

Screening Drug-Induced Arrhythmia Using Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes and Low-Impedance Microelectrode Arrays

Navarrete, E. G., Liang, P., Lan, F., Sanchez-Freire, V., Simmons, C., Gong, T., Sharma, A., Burridge, P. W., Patlolla, B., Lee, A. S., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000570 · Cited by 302

Doxorubicin-induced reactive oxygen species generation and intracellular Ca2+increase are reciprocally modulated in rat cardiomyocytes

Kim, S.-Y., Kim, S.-J., Kim, B.-J., Rah, S.-Y., Chung, S. M., Im, M.-J., & Kim, U.-H. (2006) · Experimental & Molecular Medicine · doi:10.1038/emm.2006.63 · Cited by 297

Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity

Aries, A., Paradis, P., Lefebvre, C., Schwartz, R. J., & Nemer, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401833101 · Cited by 296

Increased Expression of Death Receptors 4 and 5 Synergizes the Apoptosis Response to Combined Treatment with Etoposide and TRAIL

Gibson, S. B., Oyer, R., Spalding, A. C., Anderson, S. M., & Johnson, G. L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.205-212.2000 · Cited by 259

Different patterns of gene expression of topoisomerase II isoforms in differentiated tissues during murine development

Capranico, G., Tinelli, S., Austin, C. A., Fisher, M. L., & Zunino, F. (1992) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(92)90050-a · Cited by 258

Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms

Rochette, L., Guenancia, C., Gudjoncik, A., Hachet, O., Zeller, M., Cottin, Y., & Vergely, C. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.03.005 · Cited by 248

Fas-Mediated Apoptosis in Adriamycin-Induced Cardiomyopathy in Rats: In Vivo Study

Nakamura, T., Ueda, Y., Juan, Y., Katsuda, S., Takahashi, H., & Koh, E. (2000) · Circulation · doi:10.1161/01.cir.102.5.572 · Cited by 223

DNA damage is an early event in doxorubicin-induced cardiac myocyte death

L'Ecuyer, T., Sanjeev, S., Thomas, R., Novak, R., Das, L., Campbell, W., & Heide, R. V. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00738.2005 · Cited by 212

Adriamycin-induced Cardiomyocyte and Endothelial Cell Apoptosis: In Vitro and In Vivo Studies

Wu, S. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2110 · Cited by 197

Anthracycline-Induced Cardiotoxicity: A Review of Pathophysiology, Diagnosis, and Treatment

Raj, S., Franco, V. I., & Lipshultz, S. E. (2014) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-014-0315-4 · Cited by 196

New signal transduction paradigms in anthracycline-induced cardiotoxicity

Ghigo, A., Li, M., & Hirsch, E. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.01.021 · Cited by 194

Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-Cardiomyocytes

Maillet, A., Tan, K., Chai, X., Sadananda, S. N., Mehta, A., Ooi, J., Hayden, M. R., Pouladi, M. A., Ghosh, S., Shim, W., et al. (2016) · Scientific Reports · doi:10.1038/srep25333 · Cited by 183

Species correlations between cardiac isomyosins. A comparison of electrophoretic and immunological properties.

Clark, W. A., Chizzonite, R. A., Everett, A. W., Rabinowitz, M., & Zak, R. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83798-5 · Cited by 177

Breast cancer therapy-associated cardiovascular disease

Zagar, T. M., Cardinale, D. M., & Marks, L. B. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.171 · Cited by 155

A Review of Human Pluripotent Stem Cell-Derived Cardiomyocytes for High-Throughput Drug Discovery, Cardiotoxicity Screening, and Publication Standards

Mordwinkin, N. M., Burridge, P. W., & Wu, J. C. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9423-2 · Cited by 131

Mitochondrial Topoisomerase I (Top1mt) Is a Novel Limiting Factor of Doxorubicin Cardiotoxicity

Khiati, S., Rosa, I. D., Sourbier, C., Ma, X., Rao, V. A., Neckers, L. Μ., Zhang, H., & Pommier, Y. G. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3373 · Cited by 130

Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment

Chaudhari, U., Nemade, H., Wagh, V., Gaspar, J. A., Ellis, J. K., Srinivasan, S. P., Spitkovski, D., Nguemo, F., Louisse, J., Bremer, S., et al. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1623-5 · Cited by 102

Spatial dynamics of TRAIL death receptors in cancer cells

Twomey, J. D., Kim, S.-R., Zhao, L., Bozza, W. P., & Zhang, B. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.02.001 · Cited by 97

Systems biology approaches to adverse drug effects: the example of cardio-oncology

Brown, S.-A. N., Sandhu, N. P., & Herrmann, J. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.168 · Cited by 94

Apoptosis in Rat Cardiac Myocytes Induced by Fas Ligand: Priming for Fas-mediated Apoptosis with Doxorubicin

Yamaoka‐Tojo, M., Yamaguchi, S., Suzuki, T., Okuyama, M., Nitobe, J., Nakamura, N., Mitsui, Y., & Tomoike, H. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1132 · Cited by 90

Doxorubicin induces drug resistance and expression of the novel CD44st via NF-κB in human breast cancer MCF-7 cells

Fang, X., Jiang, H., ZHU, Y. Q., Zhang, L., Fan, Q., & Tian, Y. (2014) · Oncology Reports · doi:10.3892/or.2014.3131 · Cited by 85

Structural and functional screening in human induced-pluripotent stem cell-derived cardiomyocytes accurately identifies cardiotoxicity of multiple drug types

Doherty, K. R., Talbert, D. R., Trusk, P. B., Moran, D. M., Shell, S. A., & Bacus, S. S. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.03.008 · Cited by 82

Human Pluripotent Stem Cell-Derived Cardiomyocytes as Research and Therapeutic Tools

Aćimović, I., Vilotić, A., Pešl, M., Lacampagne, A., Dvořák, P., Rotrekl, V., & Méli, A. C. (2014) · BioMed Research International · doi:10.1155/2014/512831 · Cited by 70

TRAIL and Doxorubicin Combination Induces Proapoptotic and Antiangiogenic Effects in Soft Tissue Sarcoma In vivo

Wang, S., Ren, W., Liu, J., Lahat, G., Torres, K. E., Lopez, G., Lazar, A. J., Hayes-Jordan, A. A., Liu, K., Bankson, J. A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2443 · Cited by 60

Enhancement of TRAIL/Apo2L‐mediated apoptosis by adriamycin through inducing DR4 and DR5 in renal cell carcinoma cells

Wu, X., Kakehi, Y., Mizutani, Y., Nishiyama, H., Kamoto, T., Megumi, Y., Ito, N., & Ogawa, O. (2003) · International Journal of Cancer · doi:10.1002/ijc.10948 · Cited by 48

Change in TNF- α Receptor Expression Is a Relevant Event in Doxorubicin-Induced H9c2 Cardiomyocyte Cell Death

Chiosi, E., Spina, A., Sorrentino, A., Romano, M., Sorvillo, L., Senatore, G., D’Auria, R., Abbruzzese, A., Caraglia, M., Naviglio, S., et al. (2007) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2006.0161 · Cited by 42

Oxidative stress does not play a primary role in the toxicity induced with clinical doses of doxorubicin in myocardial H9c2 cells

Rharass, T., Gbankoto, A., Canal, C., Kurşunluoğlu, G., Bijoux, A., Panáková, D., & Ribou, A. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2653-x · Cited by 26

Fas Expression and Apoptosis Correlate With Cardiac Dysfunction in Patients With Dilated Cardiomyopathy

Yamamura, T., Nakamura, H., Yamamoto, T., Umemoto, S., Fujii, T., Kobayashi, N., & Matsuzaki, M. (1999) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.63.149 · Cited by 19

The dilemma of the strive for apoptosis in oncology: mind the heart

Perik, P. J., de Vries, E. G. E., Gietema, J. A., van der Graaf, W. T. A., Sleijfer, D. T., Suurmeijer, A. J. H., & van Veldhuisen, D. J. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.10.001 · Cited by 15

TNF receptor deficiency reveals a translational control mechanism for adriamycin-induced Fas expression in cardiac tissues

Lien, Y., Daosukho, C., & Clair, D. K. S. (2006) · Cytokine · doi:10.1016/j.cyto.2006.02.001 · Cited by 7

Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management

Rawat, P. S., Jaiswal, A., Khurana, A., Bhatti, J. S., & Navik, U. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111708 · Cited by 909

Toxicity of Doxorubicin (Dox) to different experimental organ systems

Pugazhendhi, A., Edison, T. N. J. I., Velmurugan, B. K., Jacob, J. A., & Karuppusamy, I. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.03.023 · Cited by 452

Emerging Prospects of Exosomes for Cancer Treatment: From Conventional Therapy to Immunotherapy

Nam, G., Choi, Y., Kim, G. B., Kim, S., Kim, S. A., & Kim, I. (2020) · Advanced Materials · doi:10.1002/adma.202002440 · Cited by 267

An integrative machine learning approach for prediction of toxicity-related drug safety

Lysenko, A., Sharma, A., Boroevich, K. A., & Tsunoda, T. (2018) · Life Science Alliance · doi:10.26508/lsa.201800098 · Cited by 88

Advanced human developmental toxicity and teratogenicity assessment using human organoid models

Li, M., Gong, J., Gao, L., Zou, T., Kang, J., & Xu, H. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113429 · Cited by 84